The 20 Best Merkel Cell Carcinoma Doctors Near Me in Brighton, MI

Dr Joseph Evans is originally from the Chicago suburbs, and attended the University of Iowa where he graduated with a Bachelor of Science degree in Physics. He then completed the MD-PhD program at Northwestern University Feinberg School of Medicine, where his graduate studies focused on inhibitors of cell death in cancer cells. Dr Evans entered Radiation Oncology at University of Michigan where he completed Residency.Clinically, Dr Evans sees and treats patients with gynecologic cancer, including brachytherapy, spine metastases, and benign diseases treated with radiation treatment, particularly Dupuytren's disease.Dr Evans is a physician leader in the department and the Rogel Cancer Center. He works with other faculty and staff leaders on clinical operations within the department and the interface with the Cancer Center, focusing on process improvement, quality metrics, financial stewardship, and strategy. His work streamlines workflows in the Electronic Medical Record (Epic) to improve patient care, patient experience, and clinician experience. Dr. Evans is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Prostate Cancer. Dr. Evans is board certified in Radiation Oncology.

University of Texas Southwestern in Dallas, Texas. Her clinical practice has focused on head and neck cancer, lymphoma and hematologic malignancies, CNS malignancies, lung cancer, and breast cancer. However, she is board certified and experienced in treating all disease sites. She has clinical research experience in several disease sites as well, including head and neck cancer, glioblastoma, esophageal cancer, cutaneous lymphoma, and lung cancer. Patient care is her passion, and she enjoys working with patients on a daily basis. She is a strong believer in patient education and making sure patients understand their disease and treatment options. Based on her experience developing clinical trials at Stanford, she is developing an academic program focused on the conduct of clinical trials as well as patient and physician decision-making regarding clinical trials. Her goal is to develop tools to improve clinical trial enrollment through medical team communication as well as patient and physician education. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Intraductal Papilloma.

Dr. Dragovic attended the University of Michigan for both undergraduate and medical school, and after completing radiation oncology residency at the University of Alabama at Birmingham (UAB), he returned to Ann Arbor to join the U of M Department of Radiation Oncology faculty in 2012. Since that time, he has held several roles in the Department of Radiation Oncology, with experience in multiple of the department’s community practice affiliates as well as at the main hospital. Dr. Dragovic was chosen to lead the department’s new clinic at the Brighton Center for Specialty Care and also to represent the BCSC Cancer Center as a whole as Physician Lead. He has taken on these roles with great joy and pride as it has been both a challenge and reward being a part of building a new cancer center. Dr. Dragovic’s vision for the BCSC Cancer Center is to become more or less an extension of the University Hospital Cancer Center- providing the highest quality multidisciplinary care to patients with a wide variety of cancer diagnoses, including the availability of clinical trial enrollment for appropriate patients. Clinically, Dr. Dragovic treats all disease sites and has a specific clinical interest in head & neck cancer, lung cancer, and stereotactic body radiotherapy (SBRT). Dr. Dragovic is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Laryngeal Cancer, and Breast Cancer. Dr. Dragovic is board certified in Radiation Oncology.

Michael S. Sabel, MD, FACS is the William W. Coon Collegiate Professor of Surgical Oncology in the Department of Surgery at Michigan Medicine. He completed his undergraduate training at Pennsylvania State University and obtained his medical degree from Temple University School of Medicine in Philadelphia. His general surgery residency was performed at Rush-Presbyterian-St. Lukes Medical Center in Chicago. Dr. Sabel completed an NIH-T32 research fellowship in tumor immunology and a surgical oncology fellowship at Roswell Park Cancer Institute in Buffalo, NY. Dr. Sabel joined the University of Michigan faculty in 2001. He has been listed in Best Doctors in America in Surgical Oncology every year since 2007 and has named as one of the U.S. News and World Report Top Doctors in Surgery since 2011.Clinical Specialization:Dr. Sabels clinical interests are in the area of surgical oncology, with special expertise in breast cancer and melanoma. Dr. Sabel is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Inflammatory Breast Cancer, Mastectomy, and Craniectomy. Dr. Sabel is board certified in Surgery.

Dr. Sarah Yentz received her medical degree from the University of Michigan and completed Internal Medicine residency training at Northwestern Memorial Hospital where she served as chief resident 2014-2015. She completed her fellowship in Hematology/Oncology at the University of Michigan in 2018. Dr. Yentz is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, and WT1-Related Wilms Tumor Syndromes.

Following her undergraduate and graduate studies in Virginia, Dr. Jaworski completed her residency training in Radiation Oncology at the University of Michigan. Dr. Jaworski has closely collaborated with clinical and medical physics faculty members to investigate multiple aspects of radiation treatment planning, including collaborations within the Michigan Radiation Oncology Quality Consortium. Her first-author publications have shown the durable impact of quality measures in reducing the use of prolonged radiation courses for pain relief, gains associated with automated treatment planning for head and neck cancer, and reducing toxicities associated with radiation. As a testament to her passion for patient care and clinical focus, Dr. Jaworski was inducted into the Gold Humanism Honor Society in 2022. Dr. Jaworski is board-eligible and treats all disease sites. Dr. Jaworski is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. Her clinical expertise encompasses Bone Tumor, Prostate Cancer, HER-2 Positive Breast Cancer, and Endometrial Cancer. Dr. Jaworski is board certified in Radiation Oncology.

Jeffrey H. Kozlow, MD, serves as a Clinical Associate Professor in the Section of Plastic and Reconstructive Surgery at the University of Michigan School of Medicine. A native of Southeastern Michigan, Dr. Kozlow received his Bachelors of Arts in Psychology and Chemistry from Cornell University. He graduated from Johns Hopkins University School of Medicine for his M.D. degree. He underwent Plastic Surgery Residency training at the University of Michigan followed by an additional one-year fellowship in Microvascular Reconstructive Surgery at the University of Texas – MD Anderson Cancer Center. He has returned to the University of Michigan joining the faculty in 2011. Clinical Specialization: Dr. Kozlow is clinically focused on the reconstruction of oncologic and traumatic defects. His microsurgical training allows him to perform abdominally-based breast reconstruction including DIEP and muscle-sparing TRAM flaps. He partners with members of the University of Michigan Rogel Cancer Center to provide an integrated and multi-disciplinary reconstruction for complex defects including the extremities and pelvis. His goal is to perform reconstructions that optimize the function and form that can be lost following the surgical removal of tumors. He also treats patients with primary cutaneous malignancies including melanoma and other skin cancers. Dr. Kozlow is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Eccrine Porocarcinoma, Melanoma, Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Kozlow is board certified in Plastic Surgery.

June Chan M.D. graduated from McGill University with a degree in Honors Physiology in 1991. She then attended Albany Medical College, where she was a member of the Alpha Omega Alpha society in her 3rd year. She completed her Internship training at St. Joseph Mercy Hospital in Ann Arbor, then went on to do her residency training in Radiation Oncology at the University of Michigan, where she was Chief Resident during her final year. As junior faculty, she was awarded an NIH grant to study the use of complementary medicines in cancer patients, and has published papers in the International Journal of Radiation Oncology Biology Physics, and the Journal of Clinical Oncology. Since completing her residency, she has remained on faculty in the Department of Radiation Oncology at the University of Michigan, practicing at our Providence Hospital affiliate. Dr. Chan treats a variety of disease sites including cancers of the breast, lung, head and neck, GI system and brain. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Chan is board certified in Radiation Oncology.